These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


93 related items for PubMed ID: 4771990

  • 21. Modulation of the redox potentials of FMN in Desulfovibrio vulgaris flavodoxin: thermodynamic properties and crystal structures of glycine-61 mutants.
    O'Farrell PA, Walsh MA, McCarthy AA, Higgins TM, Voordouw G, Mayhew SG.
    Biochemistry; 1998 Jun 09; 37(23):8405-16. PubMed ID: 9622492
    [Abstract] [Full Text] [Related]

  • 22. Understanding the FMN cofactor chemistry within the Anabaena Flavodoxin environment.
    Lans I, Frago S, Medina M.
    Biochim Biophys Acta; 2012 Dec 09; 1817(12):2118-27. PubMed ID: 22982476
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Differential stabilization of the three FMN redox forms by tyrosine 94 and tryptophan 57 in flavodoxin from Anabaena and its influence on the redox potentials.
    Lostao A, Gómez-Moreno C, Mayhew SG, Sancho J.
    Biochemistry; 1997 Nov 25; 36(47):14334-44. PubMed ID: 9398151
    [Abstract] [Full Text] [Related]

  • 25. Active site probes of flavoproteins. Determination of the solvent accessibility of the flavin position 8 for a series of flavoproteins.
    Schopfer LM, Massey V, Claiborne A.
    J Biol Chem; 1981 Jul 25; 256(14):7329-37. PubMed ID: 6894755
    [Abstract] [Full Text] [Related]

  • 26. The amino acid sequence of the Azotobacter vinelandii flavodoxin.
    Tanaka M, Haniu M, Yasunobu KT.
    Biochem Biophys Res Commun; 1975 Sep 16; 66(2):639-44. PubMed ID: 1180929
    [No Abstract] [Full Text] [Related]

  • 27. Conformational changes in Chondrus crispus flavodoxin on dissociation of FMN and reconstitution with flavin analogues.
    Rogers LJ, Sykes GA.
    Biochem J; 1990 Dec 15; 272(3):775-9. PubMed ID: 2268302
    [Abstract] [Full Text] [Related]

  • 28. A conformational approach to study the mode of binding of flavin mononucleotide to flavodoxin.
    Vinayaka CR, Rao VS.
    J Biomol Struct Dyn; 1984 Dec 15; 2(3):663-74. PubMed ID: 6400918
    [Abstract] [Full Text] [Related]

  • 29. Separation of the apoprotein and reconstitution of the holoprotein from the long-lived intermediate in bacterial bioluminescence.
    Murphy CL, Faini GJ, Lee J.
    Biochem Biophys Res Commun; 1974 May 07; 58(1):119-25. PubMed ID: 4831059
    [No Abstract] [Full Text] [Related]

  • 30. pH-dependent spectroscopic changes associated with the hydroquinone of FMN in flavodoxins.
    Yalloway GN, Mayhew SG, Malthouse JP, Gallagher ME, Curley GP.
    Biochemistry; 1999 Mar 23; 38(12):3753-62. PubMed ID: 10090764
    [Abstract] [Full Text] [Related]

  • 31. Protein fluorescence and solvent perturbation spectra as probes of flavin--protein interactions in the Shethna flavoprotein.
    D'Anna JA, Tollin G.
    Biochemistry; 1971 Jan 05; 10(1):57-64. PubMed ID: 5538611
    [No Abstract] [Full Text] [Related]

  • 32. Role of neighboring FMN side chains in the modulation of flavin reduction potentials and in the energetics of the FMN:apoprotein interaction in Anabaena flavodoxin.
    Nogués I, Campos LA, Sancho J, Gómez-Moreno C, Mayhew SG, Medina M.
    Biochemistry; 2004 Dec 07; 43(48):15111-21. PubMed ID: 15568803
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Mechanism of flavin mononucleotide cofactor binding to the Desulfovibrio vulgaris flavodoxin. 2. Evidence for cooperative conformational changes involving tryptophan 60 in the interaction between the phosphate- and ring-binding subsites.
    Murray TA, Foster MP, Swenson RP.
    Biochemistry; 2003 Mar 04; 42(8):2317-27. PubMed ID: 12600199
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Concurrent presence of on- and off-pathway folding intermediates of apoflavodoxin at physiological ionic strength.
    Houwman JA, Westphal AH, Visser AJWG, Borst JW, van Mierlo CPM.
    Phys Chem Chem Phys; 2018 Mar 07; 20(10):7059-7072. PubMed ID: 29473921
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.